Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Omeros Corp

NASDAQ: OMER · Life Sciences · 4 alerts · CIK 1285819

Share price
$16.68Close, Nov 16
Market cap
$1.24B
Shares outstanding
74.46MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Omeros Corp filings on SEC EDGAR ↗

4:29 PM ET 8-K
Financial Results

Omeros Financial Results

Omeros Corporation reported Q3 2026 financial results, highlighted by a 26% sequential increase in net revenue for YARTEMLEA to $35.9 million. The company reported a GAAP net loss of $57.4 million, primarily driven by a $62.0 million non-cash mark-to-market adjustment on convertible notes, while achieving positive operating cash flow of $13.3 million.

Term
Q3 2026

“YARTEMLEA sales continued to grow during the third quarter, delivering consecutive quarters of positive operating cash flow. As expected, 340B participation increased, reflecting substantial expansion of our customer base and increased outpatient use of YARTEMLEA. That momentum has continued into the fourth quarter, with YARTEMLEA revenues continuing to grow.”

Gregory A. Demopulos, M.D., Omeros’ Chairman and Chief Executive Officer
5:02 PM ET 8-K
Stock Plan Amendment

Omeros Stock Plan Amendment

Omeros Corporation granted a performance-based stock option award to CEO Gregory A. Demopulos for up to 500,000 shares at an exercise price of $17.88. The award vests across four tranches tied to stock-price hurdles ranging from $25.00 to $40.00 per share and requires continued service over a four-year period. The grant is intended to incentivize long-term shareholder value creation following the company's recent strategic milestones, including FDA approval of YARTEMLEA.

Term
5 years
9:01 PM ET Form 4
Insider Selling

Omeros VP, Finance & CAO David J. Borges Sells $419K of Stock

David J. Borges, VP, Finance & CAO, sold 20,000 shares of Omeros Corp at $20.95 a share, worth $419K in total between Sep 22, 2026 and Sep 23, 2026. Shares held after the trade: 0 (-100.0%).

Value
$419K
Shares
20,000
Average price
$20.95
Role
VP, Finance & CAO
Holding change
-100.0%
Trade date
Sep 22, 2026 to Sep 23, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.